Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
22.35
-0.92 (-3.95%)
Mar 31, 2025, 1:23 PM EDT - Market open
Edgewise Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Edgewise Therapeutics stock have an average target of 45.38, with a low estimate of 30 and a high estimate of 56. The average target predicts an increase of 103.04% from the current stock price of 22.35.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Edgewise Therapeutics stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 4 | 5 | 5 | 5 | 5 | 6 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 7 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Initiates $50 | Buy | Initiates | $50 | +123.71% | Mar 7, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $56 | Buy | Reiterates | $56 | +150.56% | Mar 4, 2025 |
| Stifel | Stifel | Hold Initiates $30 | Hold | Initiates | $30 | +34.23% | Jan 22, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $45 → $50 | Buy | Maintains | $45 → $50 | +123.71% | Dec 17, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $33 → $50 | Strong Buy | Maintains | $33 → $50 | +123.71% | Nov 27, 2024 |
Financial Forecast
Revenue This Year
n/a
from 547.79M
Revenue Next Year
n/a
EPS This Year
-1.97
from -1.45
EPS Next Year
-2.25
from -1.97
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 33.6M | 192.3M | ||
| Avg | n/a | 7.3M | 79.1M | ||
| Low | n/a | n/a | 6.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 2,545.2% | ||
| Avg | - | - | 988.5% | ||
| Low | - | - | -8.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.73 | -1.94 | -1.88 | ||
| Avg | -1.97 | -2.25 | -2.25 | ||
| Low | -2.17 | -2.48 | -3.12 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.